CARLOS SOLANO VERCET-rekin lankidetzan egindako argitalpenak (6)

2020

  1. Features of Cytomegalovirus DNAemia Blips in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Implications for Optimization of Preemptive Antiviral Therapy Strategies

    Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 5, pp. 972-977

  2. Peripheral blood regulatory T cells and occurrence of Cytomegalovirus DNAemia after unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide

    Bone Marrow Transplantation

2017

  1. Assessing the risk of cytomegalovirus DNAaemia in allogeneic stem cell transplant recipients by monitoring oxidative-stress markers in plasma

    Journal of General Virology, Vol. 98, Núm. 7, pp. 1855-1863

2014

  1. Active cytomegalovirus infection is not a risk factor for Epstein-Barr virus DNAemia in the allogeneic stem cell transplantation setting

    Clinical Transplantation

2008

  1. Enumeration of cytomegalovirus-specific interferong CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection

    Haematologica

2001

  1. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine

    Journal of Medical Virology, Vol. 65, Núm. 1, pp. 178-184